Agreement between Capillary Refill Time measured at Finger and Earlobe sites in different positions: a pilot prospective study on healthy volunteers.

Recently, the ANDROMEDA-SHOCK trial found that patients in the CRT group had an almost significant reduction in 28-day mortality and lower SOFA scores at 72 h [ 11 ], thus the doors to a novel approach to sepsis tailored on the use of CRT, which is currently under investigation with the multicenter randomized ANDROMEDA-SHOCK 2 trial (registered on www.clinicaltrial.gov NCT05057611 ) [ 12 ].

also in 1,858 other papers